Advertisement

Analytical and Bioanalytical Chemistry

, Volume 407, Issue 3, pp 991–1002 | Cite as

Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis

  • Eva Cífková
  • Michal HolčapekEmail author
  • Miroslav Lísa
  • David Vrána
  • Jiří Gatěk
  • Bohuslav Melichar
Research Paper
Part of the following topical collections:
  1. ABCs 13th Anniversary

Abstract

The comprehensive approach for the lipidomic characterization of human breast cancer and surrounding normal tissues is based on hydrophilic interaction liquid chromatography (HILIC)–electrospray ionization mass spectrometry (ESI-MS) quantitation of polar lipid classes of total lipid extracts followed by multivariate data analysis using unsupervised principal component analysis (PCA) and supervised orthogonal partial least square (OPLS). This analytical methodology is applied for the detailed lipidomic characterization of ten patients with the goal to find the statistically relevant differences between tumor and normal tissues. This strategy is selected for better visualization of differences, because the breast cancer tissue is compared with the surrounding healthy tissue of the same patient, therefore changes in the lipidome are caused predominantly by the tumor growth. A large increase of total concentrations for several lipid classes is observed, including phosphatidylinositols, phosphatidylethanolamines, phosphatidylcholines, and lysophosphatidylcholines. Concentrations of individual lipid species inside the abovementioned classes are also changed, and in some cases, these differences are statistically significant. PCA and OPLS analyses enable a clear differentiation of tumor and normal tissues based on changes of their lipidome. A notable decrease of relative abundances of ether and vinylether (plasmalogen) lipid species is detected for phosphatidylethanolamines, but no difference is apparent for phosphatidylcholines.

Keywords

Breast cancer Lipid biomarkers HILIC-HPLC/ESI-MS Quantitation Statistical analysis 

Notes

Acknowledgments

This work was supported by ERC CZ project No. LL1302 sponsored by the Ministry of Education, Youth and Sports of the Czech Republic. E.C. acknowledges the support of the grant project no. CZ.1.07/2.3.00/30.0021 sponsored by the Ministry of Education, Youth and Sports of the Czech Republic. The help of Blanka Červená and Vitaliy Chagovets (University of Pardubice) in the extraction and data analysis and Martin Hill (Institute of Endocrinology) in the statistical evaluation is acknowledged.

Supplementary material

216_2014_8272_MOESM1_ESM.pdf (1 mb)
ESM 1 (PDF 1.02 MB)

References

  1. 1.
    Pelengaris S, Khan M (2013) Wiley: OxfordGoogle Scholar
  2. 2.
    Rosen L, Rosen G (2013) http://cancer.org/: Atlanta
  3. 3.
    Thomson CA, Thompson PA (2009) Future Oncol 5:1257–1269CrossRefGoogle Scholar
  4. 4.
    Azordegan N, Fraser V, Le K, Hillyer LM, Ma DWL, Fischer G, Moghadasian MH (2013) Mol Cell Biochem 374:223–232CrossRefGoogle Scholar
  5. 5.
    Pender-Cudlip MC, Krag KJ, Martini D, Yu J, Guidi A, Skinner SS, Zhang Y, Qu XY, He CW, Xu Y, Qian SY, Kang JX (2013) Cancer Sci 104:760–764CrossRefGoogle Scholar
  6. 6.
    Lv WW, Yang TS (2012) Clin Biochem 45:127–133CrossRefGoogle Scholar
  7. 7.
    Shannon J, King IB, Moshofsky R, Lampe JW, Gao DL, Ray RM, Thomas DB (2007) Am J Clin Nutr 85:1090–1097Google Scholar
  8. 8.
    Kang JX, Liu A (2013) Cancer Met Rev 32:201–210CrossRefGoogle Scholar
  9. 9.
    Corsetto PA, Montorfano G, Zava S, Jovenitti IE, Cremona A, Berra B, Rizzo AM (2011) Lipids Health Dis. 10Google Scholar
  10. 10.
    Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, Spencer D, Berry D, Steward W, Dennison A (2009) Eur J Cancer 45:2077–2086CrossRefGoogle Scholar
  11. 11.
    Doria ML, Cotrim CZ, Simoes C, Macedo B, Domingues P, Domingues MR, Helguero LA (2013) J Cell Physiol 228:457–468CrossRefGoogle Scholar
  12. 12.
    Doria ML, Cotrim Z, Macedo B, Simoes C, Domingues P, Helguero L, Domingues MR (2012) Breast Cancer Res Tr 133:635–648CrossRefGoogle Scholar
  13. 13.
    Hua X, Zhou ZX, Yuan L, Liu SQ (2013) Anal Chim Acta 788:135–140CrossRefGoogle Scholar
  14. 14.
    Chughtai K, Jiang L, Greenwood TR, Glunde K, Heeren RMA (2013) J Lipid Res 54:333–344CrossRefGoogle Scholar
  15. 15.
    Hilvo M, Denkert C, Lehtinen L, Muller B, Brockmoller S, Seppanen-Laakso T, Budczies J, Bucher E, Yetukuri L, Castillo S, Berg E, Nygren H, Sysi-Aho M, Griffin JL, Fiehn O, Loibl S, Richter-Ehrenstein C, Radke C, Hyotylainen T, Kallioniemi O, Iljin K, Oresic M (2011) Cancer Res 71:3236–3245CrossRefGoogle Scholar
  16. 16.
    Smith RE, Lespi P, Di Luca M, Bustos C, Marra FA, de Alaniz MJT, Marra CA (2008) Lipids 43:79–89CrossRefGoogle Scholar
  17. 17.
    Hammad LA, Wu GX, Saleh MM, Klouckova I, Dobrolecki LE, Hickey RJ, Schnaper L, Novotny MV, Mechref Y (2009) Rapid Commun Mass Spectrom 23:863–876CrossRefGoogle Scholar
  18. 18.
    Kim H, Min HK, Kong G, Moon MH (2009) Anal Bioanal Chem 393:1649–1656CrossRefGoogle Scholar
  19. 19.
    Holčapek M, Jirásko R, Lísa MJ (2012) Chromatogr A 1259:3–15CrossRefGoogle Scholar
  20. 20.
    Han XL, Yang K, Gross RW (2012) Mass Spectrom Rev 31:134–178CrossRefGoogle Scholar
  21. 21.
    Yang K, Han X (2011) Metabolites 1:21–40CrossRefGoogle Scholar
  22. 22.
    Begley JKP, Redpath TW, Bolan PJ, Gilbert FJ (2012) Breast Cancer Res. 14Google Scholar
  23. 23.
    Glunde K, Jie C, Bhujwalla ZM (2004) Cancer Res 64:4270–4276CrossRefGoogle Scholar
  24. 24.
    Klomp DWJ, van de Bank BL, Raaijmakers A, Korteweg MA, Possanzini C, Boer VO, de Berg C, van de Bosch M, Luijten PR (2011) NMR Biomed 24:1337–1342CrossRefGoogle Scholar
  25. 25.
    Merchant TE, Meneses P, Gierke LW, Denotter W, Glonek T (1991) Br J Cancer 63:693–698CrossRefGoogle Scholar
  26. 26.
    Kirwan GM, Johansson E, Kleemann R, Verheij ER, Wheelock AM, Goto S, Trygg J, Wheelock CE (2012) Anal Chem 84:7064–7071CrossRefGoogle Scholar
  27. 27.
    Eriksson L, Byrne T, Johansson E, Trygg J, Vikström C (2013) Multi- and megavariate data analysis. Basic principles and applications. Third revised edition. MKS Umetrics AB, MalmöGoogle Scholar
  28. 28.
    Wold S, Sjostrom M, Eriksson L (2001) Chemom Intell Lab Syst 58:109–130CrossRefGoogle Scholar
  29. 29.
    Trygg J, Wold S (2002) J Chemom 16:119–128CrossRefGoogle Scholar
  30. 30.
    Trygg J (2002) J Chemom 16:283–293CrossRefGoogle Scholar
  31. 31.
    Folch J, Lees M, Stanley GHS (1957) Biol Chem 226:497–509Google Scholar
  32. 32.
    Lísa M, Cífková E, Holčapek MJ (2011) Chromatogr A 1218:5146–5156CrossRefGoogle Scholar
  33. 33.
    Cífková E, Holčapek M, Lísa M, Ovčačíková M, Lyčka A, Lynen F, Sandra P (2012) Anal Chem 84:10064–10070CrossRefGoogle Scholar
  34. 34.
    Cífková E, Holčapek M, Lísa M (2013) Lipids 48:915–928CrossRefGoogle Scholar
  35. 35.
    Holm S (1979) Scand J Stat 6:65–70Google Scholar
  36. 36.
    Liebisch G, Vizcaino JA, Kofeler H, Trotzmuller M, Griffiths WJ, Schmitz G, Spener F, Wakelam MJO (2013) Lipid Res 54:1523–1530CrossRefGoogle Scholar
  37. 37.
    Nagan N, Zoeller RA (2001) Prog Lipid Res 40:199CrossRefGoogle Scholar
  38. 38.
    Braverman NE, Moser AB (2012) Biochim Biophys Acta-Mol Basis Dis 1822:1442–1452CrossRefGoogle Scholar
  39. 39.
    Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, Van Veldhoven PP, Waltregny D, Daniels VW, Machiels J, Vanderhoydonc F, Smans K, Waelkens E, Verhoeven G, Swinnen JV (2010) Cancer Res 70:8117–8126CrossRefGoogle Scholar
  40. 40.
    Santos CR, Schulze A (2012) Febs J 279:2610–2623CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Eva Cífková
    • 1
  • Michal Holčapek
    • 1
    Email author
  • Miroslav Lísa
    • 1
  • David Vrána
    • 2
  • Jiří Gatěk
    • 3
  • Bohuslav Melichar
    • 2
  1. 1.Department of Analytical Chemistry, Faculty of Chemical TechnologyUniversity of PardubicePardubiceCzech Republic
  2. 2.Department of Oncology, Medical School and Teaching HospitalPalacký UniversityOlomoucCzech Republic
  3. 3.Department of Surgery, Atlas HospitalTomáš Baťa University in ZlínZlínCzech Republic

Personalised recommendations